Chimeric Therapeutics Ltd (CHM) - Cash Flow Conversion Efficiency

Latest as of June 2025: -1.172x

Based on the latest financial reports, Chimeric Therapeutics Ltd (CHM) has a cash flow conversion efficiency ratio of -1.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.31 Million ≈ $-1.64 Million USD) by net assets (AU$1.97 Million ≈ $1.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Chimeric Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Chimeric Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Chimeric Therapeutics Ltd (CHM) financial obligations for a breakdown of total debt and financial obligations.

Chimeric Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chimeric Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Turbon AG F:TUR	0.056x
Zeta Network Group NASDAQ:ZNB	-0.038x
Vanadium Resources Ltd AU:VR8	-0.009x
Semacom Integrated Tbk PT JK:SEMA	0.010x
Touchwood Entertainment Limited NSE:TOUCHWOOD	-0.092x
Ease2pay NV AS:EAS2P	0.044x
Urban Logistics Reit PLC LSE:SHED	0.028x
Domino’s Pizza Group PLC LSE:DOM	-0.351x

Annual Cash Flow Conversion Efficiency for Chimeric Therapeutics Ltd (2020–2025)

The table below shows the annual cash flow conversion efficiency of Chimeric Therapeutics Ltd from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Chimeric Therapeutics Ltd (CHM) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.97 Million ≈ $1.40 Million	AU$-7.28 Million ≈ $-5.15 Million	-3.685x	-20.75%
2024-06-30	AU$2.47 Million ≈ $1.75 Million	AU$-7.54 Million ≈ $-5.33 Million	-3.052x	-5.87%
2023-06-30	AU$5.66 Million ≈ $4.01 Million	AU$-16.32 Million ≈ $-11.54 Million	-2.882x	-463.33%
2022-06-30	AU$25.71 Million ≈ $18.19 Million	AU$-13.15 Million ≈ $-9.31 Million	-0.512x	-45.42%
2021-06-30	AU$25.13 Million ≈ $17.78 Million	AU$-8.84 Million ≈ $-6.26 Million	-0.352x	-166.12%
2020-06-30	AU$-63.91K ≈ $-45.22K	AU$-34.01K ≈ $-24.06K	0.532x	--

About Chimeric Therapeutics Ltd

AU:CHM Australia Biotechnology

Market Cap

$484.61 Million

AU$684.90 Million AUD

Market Cap Rank

#27174 Global

#1375 in Australia

Share Price

AU$0.16

Change (1 day)

-3.13%

52-Week Range

AU$0.00 - AU$0.21

All Time High

AU$0.39